Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin nasal lavage added to standard Pseudomonas eradication therapy in cystic fibrosis
2015-003881-96Phase 3Completed
- Sponsor
- Meyer Organics
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of colistimethate sodium in cystic fibrosis (CF) and Pseudomonal infection (2 arms), sponsored by Meyer Organics. Primary endpoint: Lower airway Pseudomonas aeruginosa eradication. Started Nov 2020; status: completed.
02
Drugs
colistimethate sodium
03
Conditions
cystic fibrosis (CF)Pseudomonal infection
Beyond the preview
Go deeper on 2015-003881-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003881-96.